The management of hepatocellular carcinoma (HCC) has substantially changed in the past
few decades. Improvements in patient stratification (for example, using the Barcelona Clinic …

The liver is the largest organ in the body and is generally regarded by non-immunologists as
not having lymphoid function. However, such is far from accurate. This review highlights the …

BACKGROUND & AIMS: Immunoprophylaxis reduces but does not completely eradicate
hepatitis B virus (HBV) transmission. This prospective study aims at assessing the rate and …

Objective To evaluate the benefit of mass eradication of Helicobacter pylori infection in
reducing premalignant gastric lesions. Design Mass eradication of H pylori infection was …

Chronic hepatitis B (CHB) infection is the major cause of hepatocellular carcinoma (HCC).
Primary prevention of hepatitis B infection by vaccination is effective in reducing the …

Virus-like particles (VLPs) are self-assembled structures derived from viral antigens that
mimic the native architecture of viruses but lack the viral genome. VLPs have emerged as a …

Despite major advances in the understanding and treatment of hepatitis C, a preventive
vaccine remains elusive. The marked genetic diversity and multiple mechanisms of …

Objectives To determine the duration of protection from hepatitis B vaccine given in infancy
and early childhood and asses risk factors for HBV infection and chronic infection. Methods …

Hepatocellular carcinoma is the fifth most common cancer in men and the seventh in
women, as is diagnosed in more than half a million individuals worldwide every year. In …

The interdisciplinary guidelines at the S3 level on the diagnosis of and therapy for
hepatocellular carcinoma (HCC) constitute an evidence-and consensus-based instrument …